Axsome Therapeutics, Inc. (LON:0HKF)
London flag London · Delayed Price · Currency is GBP · Price in USD
104.17
-0.74 (-0.71%)
At close: Jul 2, 2025

Axsome Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
4,0313,2752,9572,7801,0522,228
Upgrade
Market Cap Growth
47.06%10.77%6.36%164.34%-52.81%-22.43%
Upgrade
Enterprise Value
3,9653,1672,7752,6691,0042,115
Upgrade
Last Close Price
81.0767.3162.3062.3228.5862.25
Upgrade
PS Ratio
12.0510.6313.9266.94--
Upgrade
PB Ratio
97.8971.9219.7230.5791.1026.74
Upgrade
P/TBV Ratio
--29.9784.6191.1026.74
Upgrade
EV/Sales Ratio
12.4410.2813.0664.28--
Upgrade
Debt / Equity Ratio
3.973.380.980.863.180.44
Upgrade
Asset Turnover
0.760.670.590.24--
Upgrade
Inventory Turnover
2.312.162.68---
Upgrade
Quick Ratio
1.901.993.462.473.757.85
Upgrade
Current Ratio
2.032.113.632.543.757.85
Upgrade
Return on Equity (ROE)
-282.16%-231.63%-159.21%-298.97%-201.51%-70.36%
Upgrade
Return on Assets (ROA)
-26.17%-27.28%-24.86%-52.30%-56.91%-30.46%
Upgrade
Return on Capital (ROIC)
-50.01%-50.30%-39.31%-81.33%-68.00%-34.16%
Upgrade
Earnings Yield
-5.34%-7.00%-6.35%-5.59%-9.16%-3.38%
Upgrade
FCF Yield
-2.28%-3.14%-3.87%-3.50%-7.62%-2.58%
Upgrade
Buyback Yield / Dilution
-4.08%-5.48%-11.73%-8.07%-1.11%-9.37%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.